Your browser doesn't support javascript.
[Application of immunosuppressive agents in crtical coronavirus disease].
He, Zhicheng; Yang, Daiwei; Wu, Tingxin; Lu, Lili.
  • He Z; Department of Clinical Medicine, College of Medicine, Wuhan University of Science and Technology, Wuhan 430065, Hubei, China. Corresponding author: Lu Lili, Email: lulili@wust.edu.cn.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue ; 35(1): 106-109, 2023 Jan.
Article in Chinese | MEDLINE | ID: covidwho-2296324
ABSTRACT
The outbreak of novel coronavirus (SARS-CoV-2) infection has brought great harm to people's life and social development. Although SARS-CoV-2 infection is more common in mild patients at present, considering the characteristics of crtical disease, rapid progress and high mortality, the treatment of critical patients are the focus of clinical attention. Immune imbalance which is characterized by cytokine storm plays a vital role in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS), extrapulmonary multiple organ failure and even death. Therefore, the application of immunosuppressive agent in crtical coronavirus disease patients has a promising prospect. In this paper, different immunosuppressive agents and their application in crtical SARS-CoV-2 infection are reviewed, so as to provide reference for crtical coronavirus disease therapy.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Prognostic study Limits: Humans Language: Chinese Journal: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Prognostic study Limits: Humans Language: Chinese Journal: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue Year: 2023 Document Type: Article